Literature DB >> 28784982

Group A streptococcal M protein activates the NLRP3 inflammasome.

J Andrés Valderrama1,2, Angelica M Riestra1, Nina J Gao1, Christopher N LaRock1, Naveen Gupta3, Syed Raza Ali1, Hal M Hoffman1,3, Partho Ghosh4, Victor Nizet5,6.   

Abstract

Group A Streptococcus (GAS) is among the top ten causes of infection-related mortality in humans. M protein is the most abundant GAS surface protein, and M1 serotype GAS strains are associated with invasive infections, including necrotizing fasciitis and toxic shock syndrome. Here, we report that released, soluble M1 protein triggers programmed cell death in macrophages (Mϕ). M1 served as a second signal for caspase-1-dependent NLRP3 inflammasome activation, inducing maturation and release of proinflammatory cytokine interleukin-1β (IL-1β) and macrophage pyroptosis. The structurally dynamic B-repeat domain of M1 was critical for inflammasome activation, which involved K+ efflux and M1 protein internalization by clathrin-mediated endocytosis. Mouse intraperitoneal challenge showed that soluble M1 was sufficient and specific for IL-1β activation, which may represent an early warning to activate host immunity against the pathogen. Conversely, in systemic infection, hyperinflammation associated with M1-mediated pyroptosis and IL-1β release could aggravate tissue injury.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28784982      PMCID: PMC5750061          DOI: 10.1038/s41564-017-0005-6

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  47 in total

1.  Streptococcal M protein: a multipotent and powerful inducer of inflammation.

Authors:  Lisa I Påhlman; Matthias Mörgelin; Jana Eckert; Linda Johansson; Wayne Russell; Kristian Riesbeck; Oliver Soehnlein; Lennart Lindbom; Anna Norrby-Teglund; Ralf R Schumann; Lars Björck; Heiko Herwald
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 2.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

3.  Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing.

Authors:  Christopher N LaRock; Simon Döhrmann; Jordan Todd; Ross Corriden; Joshua Olson; Timo Johannssen; Bernd Lepenies; Richard L Gallo; Partho Ghosh; Victor Nizet
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

4.  Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins.

Authors:  Anatoly Severin; Elliott Nickbarg; Joseph Wooters; Shakey A Quazi; Yury V Matsuka; Ellen Murphy; Ioannis K Moutsatsos; Robert J Zagursky; Stephen B Olmsted
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

5.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Authors:  Martina Sanderson-Smith; David M P De Oliveira; Julien Guglielmini; David J McMillan; Therese Vu; Jessica K Holien; Anna Henningham; Andrew C Steer; Debra E Bessen; James B Dale; Nigel Curtis; Bernard W Beall; Mark J Walker; Michael W Parker; Jonathan R Carapetis; Laurence Van Melderen; Kadaba S Sriprakash; Pierre R Smeesters
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

6.  A molecular trigger for intercontinental epidemics of group A Streptococcus.

Authors:  Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

7.  Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages.

Authors:  Oliver Soehnlein; Ylva Kai-Larsen; Robert Frithiof; Ole E Sorensen; Ellinor Kenne; Karin Scharffetter-Kochanek; Einar E Eriksson; Heiko Herwald; Birgitta Agerberth; Lennart Lindbom
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

8.  M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.

Authors:  Heiko Herwald; Henning Cramer; Matthias Mörgelin; Wayne Russell; Ulla Sollenberg; Anna Norrby-Teglund; Hans Flodgaard; Lennart Lindbom; Lars Björck
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

Review 9.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon.

Authors:  Michael A Chattergoon; Rachel Latanich; Jeffrey Quinn; Matthew E Winter; Robert W Buckheit; Joel N Blankson; Drew Pardoll; Andrea L Cox
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

View more
  24 in total

1.  Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease?

Authors:  Teneema Kuriakose; Thirumala-Devi Kanneganti
Journal:  Circulation       Date:  2018-12-04       Impact factor: 29.690

Review 2.  Group A Streptococcus encounters with host macrophages.

Authors:  J Andrés Valderrama; Victor Nizet
Journal:  Future Microbiol       Date:  2017-12-11       Impact factor: 3.165

3.  NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology.

Authors:  Xiaolong He; Weijun Yang; Zhijie Zeng; Yi Wei; Jie Gao; Bao Zhang; Li Li; Liqun Liu; Yu Wan; Qing Zeng; Zelong Gong; Liting Liu; Hanyun Zhang; Yubin Li; Shaojie Yang; Tongtong Hu; Lixian Wu; Eliezer Masliah; Shenghe Huang; Hong Cao
Journal:  Cell Mol Immunol       Date:  2019-07-18       Impact factor: 11.530

Review 4.  Variation, Indispensability, and Masking in the M protein.

Authors:  Partho Ghosh
Journal:  Trends Microbiol       Date:  2017-08-31       Impact factor: 17.079

5.  Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group A Streptococcus infection.

Authors:  Takashi Imai; Takayuki Matsumura; Sabine Mayer-Lambertz; Christine A Wells; Eri Ishikawa; Suzanne K Butcher; Timothy C Barnett; Mark J Walker; Akihiro Imamura; Hideharu Ishida; Tadayoshi Ikebe; Tomofumi Miyamoto; Manabu Ato; Shouichi Ohga; Bernd Lepenies; Nina M van Sorge; Sho Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

6.  Streptococcal M protein promotes IL-10 production by cGAS-independent activation of the STING signaling pathway.

Authors:  Elin Movert; Julia Lienard; Christine Valfridsson; Therése Nordström; Bengt Johansson-Lindbom; Fredric Carlsson
Journal:  PLoS Pathog       Date:  2018-03-26       Impact factor: 6.823

7.  NLRP3 inflammasome-mediated microglial pyroptosis is critically involved in the development of post-cardiac arrest brain injury.

Authors:  Yuan Chang; Juan Zhu; Di Wang; Hua Li; Yihua He; Kewei Liu; Xiaoqiang Wang; Yuqin Peng; Suyue Pan; Kaibin Huang
Journal:  J Neuroinflammation       Date:  2020-07-23       Impact factor: 8.322

Review 8.  Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases.

Authors:  Jonathan R Erlich; Eunice E To; Stella Liong; Robert Brooks; Ross Vlahos; John J O'Leary; Doug A Brooks; Stavros Selemidis
Journal:  Antioxid Redox Signal       Date:  2020-05-01       Impact factor: 8.401

9.  Evaluation of IL-17D in Host Immunity to Group A Streptococcus Infection.

Authors:  Allen Washington; Nissi Varki; J Andrés Valderrama; Victor Nizet; Jack D Bui
Journal:  J Immunol       Date:  2020-10-19       Impact factor: 5.422

Review 10.  Playing With Fire: Proinflammatory Virulence Mechanisms of Group A Streptococcus.

Authors:  Shyra Wilde; Anders F Johnson; Christopher N LaRock
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.